Modalis Therapeutics Corporation Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2021
Modalis Therapeutics Corporation announced consolidated earnings results for the first quarter ended March 31, 2021. For the period, the company reported operating revenue of JPY 0 million against JPY 13 million a year ago. Operating loss was JPY 252 million against JPY 116 million a year ago. Profit attributable to owners of parent was JPY 201 million against loss of JPY 118 million a year ago. Basic earnings per share was JPY 7.07 against net loss per share of JPY 4.71 per share a year ago. Diluted earnings per share of JPY 6.66.